๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

The use of sevoflurane in acute intermittent porphyria

โœ Scribed by P. R. Evans; S. Graham; C. M. Kumar


Publisher
John Wiley and Sons
Year
2001
Tongue
English
Weight
584 KB
Volume
56
Category
Article
ISSN
0003-2409

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


A case of acute intermittent porphyria
โœ Roger Chapados; Bernard Paiement ๐Ÿ“‚ Article ๐Ÿ“… 1966 ๐Ÿ› Springer-Verlag ๐ŸŒ French โš– 203 KB
Diagnosis and therapy of acute intermitt
โœ S. Sassa ๐Ÿ“‚ Article ๐Ÿ“… 1996 ๐Ÿ› Elsevier Science ๐ŸŒ English โš– 647 KB

The porphyrias are a group of disorders caused by deficiencies in the activities of the enzymes of the heme biosynthetic pathway. As a result, abnormally elevated levels of porphyrins and/or their precursors, e.g. delta-aminolevulinic acid and porphobilinogen are produced in excess, accumulate in ti

CRIM-positive mutations of acute intermi
โœ R. Kauppinen; L. Peltonen; H. Pihlaja; P. Mustajoki ๐Ÿ“‚ Article ๐Ÿ“… 1992 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 448 KB

Acute intermittent porphyria (AIP) is a dominantly inherited metabolic disease caused by a partial deficiency of the third enzyme, porphobilinogen deaminase (PBGD), in the heme biosynthetic pathway. AIP has been divided into two subtypes according to the ratio of enzyme polypeptide concentration and